Closing the LDL-C Gap: Optimizing Lipid-Lowering Therapy in ASCVD - Episode 2
In this episode, 'Examining the 2026 ACC/AHA Dyslipidemia Guidelines for ASCVD,' the expert cardiologists explore the transition from previous guideline iterations to the current, more actionable framework for lipid management. The panelists identify several key strengths in the updated recommendations, such as lowering the LDL-C treatment threshold to 160 mg/dL for low-risk individuals and providing specific targets for non-HDL and apolipoprotein B to ensure global risk control.
A significant portion of the conversation focuses on making clinical data more formulaic and easier for practitioners to implement. Dr. Navar highlights the move toward universal Lp(a) testing and the use of concrete coronary calcium scores to guide the intensification of therapy. The experts also discuss the reintroduction of "55" as a simple, memorable target for both LDL-C and apolipoprotein B in high-risk scenarios.
The panel delves into the advantages of the PREVENT equation and the shift from 10-year to 30-year risk calculations. They emphasize that identifying risk over a longer lifespan is critical because atherosclerosis is a decades-long biological process. By starting intervention earlier, clinicians can prevent plaque buildup rather than attempting the more difficult task of regressing established plaque later in life. The discussion concludes by addressing the educational gap regarding new risk percentages, noting that a 7% or 10% score under the new equation carries a different clinical weight than older models, requiring updated communication strategies for both providers and patients.
The next episode in this series, ‘Communicating Global Cardiovascular Risk Through a Prevention Lens in ASCVD,’ features the panelists advancing their conversation on ASCVD and focusing on how clinicians can more effectively frame cardiovascular risk for patients, particularly those with high-risk conditions like type 2 diabetes, by shifting the conversation from isolated lab values to a holistic, prevention-centered approach.